133 related articles for article (PubMed ID: 199098)
1. Serum angiotensin-converting enzyme in leprosy and coccidioidomycosis.
Lieberman J; Rea TH
Ann Intern Med; 1977 Oct; 87(4):423-5. PubMed ID: 199098
[TBL] [Abstract][Full Text] [Related]
2. Serum lysozyme in leprosy.
Naik SS; Gurnani S
Lepr India; 1980 Oct; 52(4):501-7. PubMed ID: 7464056
[TBL] [Abstract][Full Text] [Related]
3. Serum angiotensin-converting enzyme in leprosy.
Dhople AM; Howell PC; Williams SL; Zeigler JA; Storrs EE
Indian J Lepr; 1985; 57(2):282-7. PubMed ID: 3001195
[TBL] [Abstract][Full Text] [Related]
4. Rifampin therapy of lepromatous leprosy.
Am J Trop Med Hyg; 1975 May; 24(3):475-84. PubMed ID: 1098495
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
Waters MF; Rees RJ; Sutherland I
Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
[No Abstract] [Full Text] [Related]
6. The therapeutic effect of 4,4'-diacetyldiamino-diphenylsulfone (DADDS) in leprosy.
Shepard CC; Tolentino JG; McRae DH
Am J Trop Med Hyg; 1968 Mar; 17(2):192-201. PubMed ID: 4870563
[No Abstract] [Full Text] [Related]
7. A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.
Garraud O; Ribierre O; Bach MA
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):38-45. PubMed ID: 2940306
[TBL] [Abstract][Full Text] [Related]
8. Serum and tissue lysozyme in leprosy.
Rea TH; Taylor CR
Infect Immun; 1977 Dec; 18(3):847-56. PubMed ID: 591069
[TBL] [Abstract][Full Text] [Related]
9. Assessment of serum angiotensin-converting enzyme as a marker of activity in sarcoidosis: a study of 31 patients with erythema nodosum.
Teirstein AS; Krumholtz S
Mt Sinai J Med; 1987 Feb; 54(2):144-6. PubMed ID: 3033477
[No Abstract] [Full Text] [Related]
10. Soluble serum interleukin 2 receptor levels in leprosy patients.
Tung KS; Umland E; Matzner P; Nelson K; Schauf V; Rubin L; Wagner D; Scollard D; Vithayasai P; Vithayasai V
Clin Exp Immunol; 1987 Jul; 69(1):10-5. PubMed ID: 3115652
[TBL] [Abstract][Full Text] [Related]
11. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
[TBL] [Abstract][Full Text] [Related]
12. Serum macrophage migration inhibition activity in patients with leprosy.
Rea TH; Yoshida T
J Invest Dermatol; 1982 Nov; 79(5):336-9. PubMed ID: 6752294
[TBL] [Abstract][Full Text] [Related]
13. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
Schwerer B; Meeker HC; Sersen G; Levis WR
Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
[TBL] [Abstract][Full Text] [Related]
14. Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) leprosy.
Touw Langendijk EJ; van Diepen TW; Harboe M; Belehu A
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):305-11. PubMed ID: 6358061
[TBL] [Abstract][Full Text] [Related]
15. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
[No Abstract] [Full Text] [Related]
16. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
17. Bacteriological status (point prevalence) of lepromatous outpatients under sulfone treatment.
Quagliato R; Bechelli LM; Almeida JO; Araujo Arantes MA
Bull World Health Organ; 1975; 52(1):57-62. PubMed ID: 764995
[TBL] [Abstract][Full Text] [Related]
18. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
[No Abstract] [Full Text] [Related]
19. [Histoid leprosy with erythema nodosum leprosum].
Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
[TBL] [Abstract][Full Text] [Related]
20. Serum beta-glucuronidase in subtypes of leprosy.
George J; Rajendran M; Bhatia VN
Indian J Med Res; 1990 Mar; 91():106-10. PubMed ID: 2345017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
